Publications (original articles or review articles) published in 2023 from OUS - Section for sarcoma and melanoma
22 publications found
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
Br J Surg (in press)
DOI 10.1093/bjs/znad309, PubMed 37758514
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
JCO Precis Oncol, 7, e2200351
DOI 10.1200/PO.22.00351, PubMed 36724411
Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
Anticancer Res, 43 (5), 2031-2039
DOI 10.21873/anticanres.16364, PubMed 37097689
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Eur J Cancer, 192, 113245
DOI 10.1016/j.ejca.2023.113245, PubMed 37598656
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
BMJ Open, 13 (3), e070071
DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
Cells, 12 (5)
DOI 10.3390/cells12050820, PubMed 36899955
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
Clin Cancer Res, 29 (17), 3313-3319
DOI 10.1158/1078-0432.CCR-22-3980, PubMed 37014660
Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
Front Med (Lausanne), 9, 1051825
DOI 10.3389/fmed.2022.1051825, PubMed 36733936
First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Front Med (Lausanne), 10, 1070362
DOI 10.3389/fmed.2023.1070362, PubMed 36936230
Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study
Int J Qual Stud Health Well-being, 18 (1), 2204635
DOI 10.1080/17482631.2023.2204635, PubMed 37092307
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nat Commun, 14 (1), 3375
DOI 10.1038/s41467-023-39097-x, PubMed 37291203
Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
Mol Oncol (in press)
DOI 10.1002/1878-0261.13514, PubMed 37622176
Outcome of rare primary malignant bone sarcoma (RPMBS) treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S)
Cancer (in press)
DOI 10.1002/cncr.34964, PubMed 37530385
Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
Ann Surg Oncol (in press)
DOI 10.1245/s10434-023-13964-9, PubMed 37481493
ASO Visual Abstract: Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
Ann Surg Oncol (in press)
DOI 10.1245/s10434-023-14105-y, PubMed 37589802
Effect of Intraperitoneal 224Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
Technol Cancer Res Treat, 22, 15330338231192902
DOI 10.1177/15330338231192902, PubMed 37574949
Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
Radiother Oncol, 187, 109810
DOI 10.1016/j.radonc.2023.109810, PubMed 37468069
Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
Support Care Cancer, 31 (6), 352
DOI 10.1007/s00520-023-07810-7, PubMed 37233829
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
Cancer Treat Rev, 120, 102625 (in press)
DOI 10.1016/j.ctrv.2023.102625, PubMed 37738712
Sarcoma care in the era of precision medicine
J Intern Med (in press)
DOI 10.1111/joim.13717, PubMed 37643281
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
JAMA Netw Open, 6 (3), e234149
DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452